医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Charlie Kinemura Joins Foresight Group as a Senior Vice President, SME on Argus Safety Japan

2015年08月18日 AM09:00
このエントリーをはてなブックマークに追加


 

TOKYO

Industry veteran and a leader of Argus Safety Japan (Argus J), Hisayoshi Charlie Kinemura has joined Foresight Group as Senior Vice President. With his in depth knowledge and experiences in the design and implementation of Argus J for numerous clients, Charlie will play a leading role as an SME for Foresight’s Argus J customers.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150817005370/en/

Charlie Kinemura, SVP of Foresight Group (Photo: Business Wire)

Charlie Kinemura, SVP of Foresight Group (Photo: Business Wire)

“With Charlie’s proven track record of achieving success with his previous assignments on Argus Safety Japan projects, we believe that his deep understanding of Argus J and the Japanese regulations and culture will support Foresight in our efforts to remain a trusted and reliable partner of Pharmaceutical industry in Japan,” said Brian Dinardo, Co-CEO and Director, Foresight.

While at Relsys, the original developer of Argus Safety Suite, as a Product Manager, Charlie, and before him Keisuke (KC) Katsuyama who also has joined Foresight in May of this year, designed and led the development to introduce Argus Safety Japan, which is now widely used by a large number of Japanese Pharma companies. He continued his product strategy work through Oracle after its acquisition of Relsys for multiple releases of Argus J, and also led Oracle’s Japanese life science product strategy as Director. During his work at Oracle as well as his previous position as Vice President, Japan at RxLogix Corporation, he led numerous Argus and Argus J projects successfully for multiple clients.

Charlie holds an Engineer’s degree in Computer Science from San Diego State University as well as an Economics degree from Toyo University, Japan.

About Foresight

Foresight Group is a global management and technology services company focused exclusively on pharmacovigilance and risk management. It offers a full range of services with pharmacovigilance experts in every major pharmaceutical market in the world: North America, Europe and Japan. Its best-in-class partnership with Oracle for the implementation of Oracle Argus Safety Suite coupled with its deep expertise in drug safety lets Foresight offer clients the most comprehensive pharmacovigilance services and solutions available in the industry. All of its services and solutions are delivered with precise, timely and cost-effective execution to help the clients achieve and sustain regulatory compliance and manage risk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150817005370/en/

CONTACT

Foresight Group Japan K.K.
Mihoko Senda, +81-3-5404-3440
www.foresightgroup.com/j

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc